FDA reverses course, will review Moderna's mRNA flu vaccine
Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...
FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal
The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for the upcoming influenza season.
PhillyVoiceOpinion
FDA's abrupt flip‑flop on Moderna's mRNA flu shot highlights growing risks to drugmakers of investing in vaccines
Incentives to bring vaccines to market are shrinking. Drugmakers are scaling back research investments and cutting jobs.
Moderna says FDA to review its flu vaccine after reversing course
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
FDA Refuses to Review Moderna’s New Flu Shot
The U.S. Food and Drug Administration (FDA) recently informed Moderna that it would not review the company’s application for approval of its new flu vaccine, which is its first using mRNA technology ...
Straight Arrow News (English) on MSN
FDA to review Moderna's mRNA flu vaccine after initial rejection
Moderna announced that the FDA will review its new mRNA flu vaccine, a reversal less than two weeks after the agency refused to do so. The post FDA to review Moderna's mRNA flu vaccine after initial ...
FDA refuses Moderna's application for new mRNA flu vaccine
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
Hosted on MSN
FDA declines to review Moderna’s seasonal flu mRNA vaccine
The US Food and Drug Administration (FDA) has refused to review Moderna’s seasonal influenza jab, mRNA-1010, as the shifting vaccine landscape within the country continues to prove volatile for pharma ...
The Baltimore Sun
FDA agrees to review Moderna mRNA flu vaccine after initial refusal-to-file
The Food and Drug Administration reversed course on Wednesday and agreed to formally review Moderna’s new flu vaccine that uses mRNA technology, the company announced in a news release. Earlier this ...
The Hill
FDA reverses course, will review Moderna’s mRNA flu vaccine candidate
The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.
Detroit News
FDA reverses course and will review Moderna’s mRNA-based flu shot
The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...
Healio
FDA reverses decision, will review Moderna’s mRNA flu vaccine
Please provide your email address to receive an email when new articles are posted on . The FDA will now review an application for Moderna’s mRNA-1010 influenza vaccine. The agency initially rejected ...